Latin America Autoimmune Diagnostics Market Report 2021
The Latin America Autoimmune Diagnostics Market was worth $ 1.57 billion in 2016 and estimated to reach $ 1.87 billion by the end of 2021 with a growing potential of 3.60%.
(EMAILWIRE.COM, June 06, 2018 ) An autoimmune disease is a condition in which your immune system mistakenly attacks your body. The immune system normally guards against germs like bacteria and viruses. When it senses these foreign invaders, it sends out an army of fighter cells to attack them. Normally, the immune system can tell the difference between foreign cells and your own cells. In an autoimmune disease, the immune system mistakes part of your body — like your joints or skin — as foreign. It releases proteins called autoantibodies that attack healthy cells. Some autoimmune diseases target only one organ. Type 1 diabetes damages the pancreas. Other diseases, like lupus, affect the whole body.
View sample and decide: https://www.marketdataforecast.com/market-reports/latin-america-autoimmune-diagnostics-market-1194/request-sample
Government organizations along with related associations strive to curb such high healthcare costs and simultaneously provide improved diagnostic and therapeutic solutions to the patients. This has resulted in increased funding by the NIH for R&D programs related to autoimmune diseases. Moreover, presence of favorable government initiatives aimed at curbing incidence of these diseases and developing viable diagnostic & treatment options is expected to drive market growth over the forecast period.
Growing volume of autoimmune diagnostic procedures has heightened the need for instruments and facilities rendering faster and effective results. In an attempt to cater to ever-increasing procedure volumes, diagnostic laboratories are rapidly moving toward automation. Lab automation helps decrease workload via rapid turnaround times and helps generate standardized & reproducible results. Research and diagnostics institutes over the globe are undertaking initiatives in compliance with government organizations owing to rising prevalence of autoimmune disorders and consequent rise in healthcare expenditure. According to the data published by the National Institutes of Health (NIH), these disorders have been ranked as one of the top ten disorders leading to increasing mortality rate amongst women.
To know more read: https://www.marketdataforecast.com/market-reports/latin-america-autoimmune-diagnostics-market-1194/
Geographic Segmentation for the Latin America market is done into Mexico, Brazil and Argentina. Brazil is one of the leading markets in Latin America and is expected to continue being so during the forecast period. The Latin America Autoimmune Diagnostics Market was worth $ 1.57 billion in 2016 and estimated to reach USD 1.87 billion by the end of 2021 with a growing potential of 3.60%.
Major companies in the Latin America Autoimmune diagnostics market are Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli lilly, Glaxosmithkline Plc.
About MarketDataForecast™
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
Contact Information:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
View sample and decide: https://www.marketdataforecast.com/market-reports/latin-america-autoimmune-diagnostics-market-1194/request-sample
Government organizations along with related associations strive to curb such high healthcare costs and simultaneously provide improved diagnostic and therapeutic solutions to the patients. This has resulted in increased funding by the NIH for R&D programs related to autoimmune diseases. Moreover, presence of favorable government initiatives aimed at curbing incidence of these diseases and developing viable diagnostic & treatment options is expected to drive market growth over the forecast period.
Growing volume of autoimmune diagnostic procedures has heightened the need for instruments and facilities rendering faster and effective results. In an attempt to cater to ever-increasing procedure volumes, diagnostic laboratories are rapidly moving toward automation. Lab automation helps decrease workload via rapid turnaround times and helps generate standardized & reproducible results. Research and diagnostics institutes over the globe are undertaking initiatives in compliance with government organizations owing to rising prevalence of autoimmune disorders and consequent rise in healthcare expenditure. According to the data published by the National Institutes of Health (NIH), these disorders have been ranked as one of the top ten disorders leading to increasing mortality rate amongst women.
To know more read: https://www.marketdataforecast.com/market-reports/latin-america-autoimmune-diagnostics-market-1194/
Geographic Segmentation for the Latin America market is done into Mexico, Brazil and Argentina. Brazil is one of the leading markets in Latin America and is expected to continue being so during the forecast period. The Latin America Autoimmune Diagnostics Market was worth $ 1.57 billion in 2016 and estimated to reach USD 1.87 billion by the end of 2021 with a growing potential of 3.60%.
Major companies in the Latin America Autoimmune diagnostics market are Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli lilly, Glaxosmithkline Plc.
About MarketDataForecast™
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
Contact Information:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results